まとめ
アルファ1-アドレノ受容体アゴニストは,神経細胞の興奮性を高めます. この研究は,セロトナーギーニューロンにおける早期の一時的な外向き電流 (IA) の抑制が,ペースメーカーの活動を加速し,この効果に貢献することを示しています.
科学分野:
- 神経科学は神経科学である.
- 薬理学 薬理学とは
- 細胞電気生理学 細胞電気生理学
背景:
- アルファ1-アドレノ受容体アゴニストは,哺乳類の中央神経系の神経刺激性を高めます.
- この興奮は,ゆっくりとした脱極化と入力抵抗の増加を伴うもので,おそらく,カリウムの導電性が低下しているためである.
- アルファ1媒介の興奮における電圧依存の臨時電流の役割は不明である.
研究 の 目的:
- アルファ1-アドレノ受容体媒介刺激における早期の一時的な外向き電流 (IA) の関与を調査する.
- IA抑制が,アルファ1-アゴニストがセロトナーギーニューロンに及ぼす効果に寄与するかどうかを判断する.
主な方法:
- シングルエレクトロドの電圧クランプの記録が,セロトナーギーニューロンに記録されている.
- ノラドレナリンとアルファ1アゴニストフェニルエフリンの使用方法.
- 早期の臨時向外電流 (IA) 動態の分析.
主要な成果:
- セロトナーギーニューロンにおいて,早期の一時的な外向き電流 (IA) が特定されました.
- ノラドレナリンとフェニルエフリンは,このIA電流を抑制しました.
- IAの抑制は,ペースメーカー活動の加速と相関することが観察されました.
結論:
- 早期の臨時向外電流 (IA) は,セロトナーギーニューロンに存在します.
- アルファ1-アドレノ受容体アゴニストは,これらのニューロンにおけるIAを抑制する.
- IA抑制は,アルファ1-アゴニストによって誘発されるペースメーカー活動の加速を部分的に説明します.
関連する概念動画
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Adrenergic Receptors (Adrenoceptors): Classification
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...


